SynthesisBMC endocrine disorders2024

Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis.

Muhammed Shabil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.